Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 2,061,819 | 2,064,602 | 2,474,898 | 2,722,462 | 2,751,845 |
| Cost of Goods | 1,046,824 | 1,040,985 | 1,327,387 | 1,420,159 | 1,890,565 |
| Gross Profit | 1,014,995 | 1,023,617 | 1,147,511 | 1,302,303 | 861,280 |
| Operating Expenses | 1,059,814 | 1,112,150 | 1,326,707 | 1,286,131 | 699,574 |
| Operating Income | -43,995 | -87,548 | -178,809 | 16,331 | 162,271 |
| Interest Expense | 15,887 | 18,799 | 19,460 | 18,049 | 14,746 |
| Other Income | 3,026 | 14,813 | 4,430 | 8,793 | 8,273 |
| Pre-tax Income | -56,856 | -91,534 | -193,839 | 7,075 | 155,798 |
| Income Tax | -2,874 | -13,572 | -13,488 | 11,238 | 53,839 |
| Net Income Continuous | -53,982 | -77,962 | -180,351 | -4,163 | 101,959 |
| Net Income Discontinuous | N/A | N/A | -74,922 | -84,127 | 6,964 |
| Net Income | $-53,982 | $-77,962 | $-255,273 | $-88,290 | $108,923 |
| EBITDA(a) | $-43,995 | $-87,548 | $-178,809 | $16,331 | $162,271 |